جست‌وجوی استاد و پژوهشگر

Paulina Flanneryمشاهده پروفایل

مدرس

• Microbial Pathogens
• Virology
• Molecular Diagnostics
• +۵ مورد دیگر

Dr. Paulina Flannery is a Lecturer in Molecular Biology/Biotechnology at Bangor University's Faculty of Science and Health, within the Department of Bioveterinary and Microbial Sciences. She obtained her PhD in Microbiology from the National University of Ireland, Galway, focusing on norovirus contamination in shellfish and public health implications. Her expertise includes virology, molecular diagnostics, and veterinary medicine, with a current focus on microbial pathogens and bacteriophage therapy to combat antibiotic resistance. She has authored over 35 peer-reviewed articles and collaborates internationally on viral diagnostics and biosafety training. Her research spans veterinary virology, including work at the Pirbright Institute on high-consequence animal viruses and development of molecular diagnostics. She actively contributes to the UN Sustainable Development Goals, particularly in addressing health and environmental challenges. Notable collaborations include developing high-throughput sequencing methods and training programs for exotic virus identification. Recent press coverage highlights her work on estuarine microbial dynamics and pathogen management. While currently accepting PhD students, no formal advisees are listed. Her contributions to rapid diagnostic tools for viral pathogens underscore her commitment to advancing veterinary and public health solutions.

Hannah Claphamمشاهده پروفایل

استادیار

• Infectious Disease Dynamics and Control
• Vaccination Impact Analysis
• Dengue Epidemiology
• +۳ مورد دیگر

Hannah Clapham is an Assistant Professor and Programme Leader (Infectious Diseases) at the Saw Swee Hock School of Public Health, National University of Singapore. Her research focuses on infectious disease dynamics, vaccination impact, and epidemiology of dengue and Japanese encephalitis. She holds a PhD in Disease Dynamics from Imperial College London and has held roles including Head of the Mathematical Modelling Group at the Oxford University Clinical Research Unit in Vietnam. Her work integrates mathematical models with public health policy to address global health challenges, particularly in resource-limited settings. Education: BA Hons Mathematics, University of Oxford (2004-2007) MSc Modern Epidemiology, Imperial College London (2008-2009) PhD Disease Dynamics, Imperial College London (2009-2013) Research Interests: Her research emphasizes quantitative approaches to understand disease transmission, assess vaccine effectiveness, and inform policy. Key themes include: Mathematical modeling of dengue and arbovirus outbreaks Impact of vaccination strategies on disease control Serological data analysis to infer infection history Public health responses to pandemics (e.g., SARS-CoV-2) Media Contributions: Dr. Clapham frequently engages with media to explain public health issues, including commentaries on Singapore’s dengue outbreaks, pandemic preparedness, and vaccination strategies for Channel NewsAsia , The Straits Times , and others. Grants & Collaborations: Her career includes leadership in interdisciplinary projects, such as the Vaccine Impact Modelling Consortium and studies on pathogen genomics in Southeast Asia. She collaborates with global health organizations to translate research into actionable policies.

Alfredo Mayorمشاهده پروفایل

استاد پژوهشی

• Malaria
• Neglected Parasitic Diseases

Alfredo Mayor is a Research Professor at the Barcelona Institute for Global Health (ISGlobal), specializing in Malaria and neglected parasitic diseases. His research employs a discovery-oriented approach focused on Mozambique, combining genomic tools, epidemiological methods, and clinical trials to develop malaria surveillance strategies. Core principles include advancing scientific knowledge, prioritizing programmatic needs through National Malaria Control Program collaborations, translational host-parasite biology research, and capacity building in endemic regions. Research focuses on: Cost-effective malaria stratification for interventions Intervention efficacy assessment Early parasite threat detection Transmission reservoir targeting National surveillance capacity expansion His publications demonstrate consistent focus on genomic surveillance, molecular diagnostics, and epidemiological modeling of malaria in Mozambique. Articles frequently address the intersection of malaria with other infectious diseases like HIV and COVID-19, emphasizing public health applications in resource-limited settings.

Helen Nobleمشاهده پروفایل

استاد

• Chronic Kidney Disease
• Palliative Care
• Qualitative Research Methods
• +۳ مورد دیگر

Helen Noble is a Professor of Nursing and Director of Postgraduate Research at the School of Nursing and Midwifery, Queen’s University Belfast. She leads international research in nephrology, palliative care, and arts-based interventions for kidney patients. Her roles include supervising PhD candidates, designing postgraduate training programs, and advocating for patient-centered care. She is a Fellow of the Higher Education Authority and has received accolades such as the Walls Bursary and Donna Lamping Award. Her research focuses on improving care for patients with chronic kidney disease, end-stage renal disease, and palliative needs. Notable initiatives include the UK Renal Arts Group, which uses creative arts to enhance patient well-being, and the Compassionate Mindful Resilience (CMR) program for kidney patients. She has secured funding from NIHR, Marie Curie, and other bodies. Teaching responsibilities include modules like Renal Nursing and Renal Replacement Therapies. She serves as an external examiner for nursing programs at City University London and University of Hertfordshire. Her grants and projects span caregiver support, palliative care partnerships, and mindfulness interventions in healthcare. Awards include the RCN Impact Award 2022 for her mindfulness program for PhD students. Her work is cited in international guidelines and disseminated through conferences, media, and collaborations with global organizations like the EDTNA/ERCA Research Board.

• Digital Health
• Children and Young People's Nursing
• Virtual Reality in Healthcare Education
• +۷ مورد دیگر

Dr. Heidi Singleton is a Senior Lecturer in Children and Young People’s Nursing at Bournemouth University’s Faculty of Health and Social Sciences. She specializes in Digital Health, Virtual Reality applications in nursing education, and dermatological care. Her research focuses on improving healthcare outcomes for children through innovative technologies like VR simulations for training and symptom management. Programme Lead for Children and Young People’s Nursing Programme National Selection Committee Member for the NIHR Undergraduate Student Internship Programme Education Background: PhD: Virtual Technologies in Nurse Education (Bournemouth University, 2020) MSc: Education (2015) BSc (Hons) in Children’s Nursing (University of Surrey, 2001) Research Interests: Her work integrates digital health solutions with clinical practice, particularly in managing conditions like eczema through VR-based interventions. She leads projects like the 'Eczema Igloo'—a VR tool to distract children from itch—supported by HEIF funds. Her methodological contributions include pairing Critical Realism with PLS-SEM for evaluating VR’s educational impact. Key Contributions: Heidi has published extensively on VR in nursing education and dermatology, including Cochrane Reviews on eczema interventions. Her funded projects address skin cancer detection models and pediatric mental health simulations. She is a Fellow of the Higher Education Academy and has received awards for research and teaching innovation. Grants and Advising: PI: £39K HEIF Project on the Eczema Igloo Supervisor of 4 PhD students focusing on nursing education, skin cancer, and mental health Led collaborative efforts with experts in computer science, dermatology, and education to develop immersive technologies for healthcare training and patient care.

Samuel D. Towneمشاهده پروفایل

دانشیار

• Public Health
• Public Policy
• Social Determinants of Health
• +۵ مورد دیگر

Samuel D. Towne, Ph.D., MPH, CPH, FAAHB, is an Associate Professor at the University of Central Florida's School of Global Health Management and Informatics. His research emphasizes public health, focusing on social and structural determinants of health, aging populations, built environments, and global health disparities. He has authored over 90 peer-reviewed articles and received national recognition, including awards from NIH, APHA, and AAHB. Education: Ph.D. in Health Services Policy and Management from the University of South Carolina's Arnold School of Public Health Past Affiliation: Principal Investigator at the Center for Population Health and Aging (CPHA), Texas A&M University Dr. Towne's work explores intersections of public health, urban planning, and healthcare policy, particularly in diabetes management, fall prevention, and health equity. Recent studies analyze diabetes-related costs, social determinants of A1C control, and transit interventions for obesity prevention. His scientific awards include multiple NIH Extramural Loan Repayment Program awards, the Judy K. Black Early Career Research Award (AAHB), and Fellow status at AAHB. Internal recognition includes tenure/promotion (2023) and a Research Incentive Award (2024) at UCF. Dr. Towne has contributed to NIH-funded projects such as NIH-R01 grants on public transportation and obesity prevention and has collaborated on initiatives addressing dementia-friendly communities. His research bridges global and U.S.-based studies, emphasizing rurality, aging, and health disparities.

Marianna Virtanenمشاهده پروفایل

استاد

• Mental Health
• Occupational Health
• Work Capacity
• +۳ مورد دیگر

Marianna Virtanen is a Professor at the University of Eastern Finland, affiliated with the School of Educational Sciences and Psychology within the Philosophical Faculty. She holds PhDs in Psychology (University of Helsinki) and Epidemiology (UCL, UK), and is a docent in occupational health. Her research focuses on working life dynamics, mental health, work capacity, and sickness absence. Current projects include leveraging digital data pools for healthcare workload assessment (Academy of Finland’s 'Digital Humanities' program) and climate change impacts on health (Academy of Finland’s 'Climate Change and Health' program). Collaborations include the Finnish Institute of Occupational Health, Karolinska Institutet, and University of Helsinki. Key research areas span occupational health, work-related stress, and health policy. She leads studies on workplace interventions for mental health support, return-to-work strategies, and the socioeconomic determinants of health. Projects emphasize interdisciplinary approaches, combining epidemiological methods with register-based data and longitudinal cohort analyses. Her work has generated over 150 peer-reviewed articles, focusing on topics like shift work health impacts, violence in healthcare, and psychosocial work environment dynamics. She has advised on EU policy guidelines for workplace mental health practices and contributed to national and international health initiatives. Marianna Virtanen’s contributions bridge academic research with practical applications for improving workplace health and reducing disparities in health outcomes.

Armaghan-e-Rehman Mansoorمشاهده پروفایل

استادیار

• Infectious Diseases
• Antimicrobial Stewardship
• Endocarditis
• +۳ مورد دیگر

Armaghan-e-Rehman Mansoor, MBBS, serves as an Assistant Professor in the Department of Internal Medicine within the Infectious Disease division at the University of Kentucky College of Medicine. His academic appointment spans both the Department of Internal Medicine and the Infectious Disease specialty unit, where he contributes to clinical care, research, and likely teaching missions in complex infectious disease management. Dr. Mansoor's research program centers on antimicrobial stewardship with specialized expertise in cardiac device-related infections (particularly endocarditis), invasive fungal infections, antimicrobial resistance epidemiology, and outpatient parenteral antimicrobial therapy (OPAT) program optimization. His work emphasizes evidence-based interventions to improve antimicrobial use and patient outcomes through multidisciplinary collaboration across cardiology, transplant medicine, and critical care settings. Analysis of his 15 most recent publications (2024-2025) reveals consistent focus on outcomes research in device-associated infections (LVADs, transplants), antimicrobial stewardship implementation for urinary tract infections and neutropenic fever, and rigorous evaluation of OPAT program metrics. His studies frequently employ multicenter retrospective designs to address pressing clinical questions in immunocompromised and critically ill populations, with particular attention to translating findings into practical stewardship initiatives that combat antimicrobial resistance.

Kunle Kassimمشاهده پروفایل

استاد

• Microbial Pathogenesis
• Antimicrobial Drug Development
• Maternal Milk Immunology
• +۳ مورد دیگر

Dr. Kunle Kassim is a Professor and Chair of the Department of Microbiology in the College of Medicine at Howard University, Washington, D.C. His academic roles include teaching and research in microbial pathogenesis, drug discovery, and global health. He holds a PhD and MPH from the University of Minnesota and Johns Hopkins University, respectively. Education: PhD in Microbiology, University of Minnesota, 1975 MPH in Epidemiology, Johns Hopkins School of Public Health, 1980 Research Focus: Dr. Kassim’s work spans microbial pathogenesis, antimicrobial drug development, and epidemiology. He has conducted field and laboratory research on malaria, schistosomiasis, and maternal breast milk immunology, often collaborating with institutions like Obafemi Awolowo University (Nigeria) and Howard University’s Pharmacology Department. His research has been supported by NIH, WHO, and USAID grants. Awards: Two Kaiser Permanente Excellence in Teaching Awards Multiple Teacher of the Year Awards from Howard’s College of Medicine Student Council Mentoring Awards from the American Heart Association and NIH Summer Research Programs Advising & Grants: Trained numerous PhD students and contributed to Howard’s global health curriculum. Co-founded the Howard University summer training program in tropical disease research across Africa. Developed a Global Health course addressing disease outbreak control, water sanitation, and vaccine distribution strategies. Labs & Collaborations: Collaborations include projects with Nigerian universities and Howard’s Pharmacology Department. Research has focused on diagnostics for urinary schistosomiasis, malaria’s impact on pregnancy, and bioactive plant extracts against cancer and malaria.

Jana Meixnerمشاهده پروفایل

پژوهشگر

• Evidence-Based Medicine
• Public Health
• Epidemiology
• +۳ مورد دیگر

Dr. Jana Meixner is an Academic Associate at the University for Continuing Education Krems and collaborates with Cochrane Austria. Her work focuses on Evidence-Based Medicine, Public Health, and Epidemiology. She actively contributes to research projects such as "Medizin Transparent 2024" and "Implementation of cancer screening in Europe," funded by EU and public institutions. Her research emphasizes combating health misinformation, improving healthcare communication, and advancing systematic reviews in areas like influenza management and animal-assisted interventions. She frequently lectures on topics such as fake science, reliable health information, and evidence-based practices, engaging audiences ranging from medical professionals to the general public. Her publications span peer-reviewed journals and media outlets, addressing critical issues in healthcare transparency, patient education, and pandemic responses. She is affiliated with the Evidence-Based Health Research group at her university and actively participates in interdisciplinary collaborations to bridge gaps between scientific evidence and practical healthcare applications. Projects: Leading roles in EU-funded cancer screening initiatives and transparency-focused health communication programs. Grants: Secured funding from EU and Austrian public health institutions. Labs/Teams: Cochrane Austria, Evidence-Based Health Research group at University for Continuing Education Krems.

G. Boyd Padgettمشاهده پروفایل

استاد

• Row Crop Pathology
• Disease Management
• Fungicide Application
• +۲ مورد دیگر

G. Boyd Padgett is Professor and Extension/Research Row Crop Plant Pathologist at Louisiana State University's College of Agriculture. He serves as State Small Grains and Peanut Specialist and Interim Soybean Specialist, developing disease management programs for major Louisiana crops including corn, cotton, grain sorghum, peanut, soybean, and small grains. Education: Educational background not explicitly provided in text. Dr. Padgett's research focuses on the epidemiology and management of fungal pathogens affecting row crops. His work emphasizes field-based solutions through variety evaluation, fungicide efficacy trials, and integrated disease management strategies. He has secured over $3 million in grant funding from organizations including the United Soybean Board, USDA, and National Peanut Board. Recent publications address soybean rust monitoring systems, fungicide resistance mechanisms in Cercospora species, nematode management in cotton, and integrated disease management strategies for wheat and soybeans. His extension program delivers practical disease management solutions through over 170 local, state, and national presentations and media engagements. Dr. Padgett teaches plant disease management courses and mentors graduate students. His extension publications provide disease management guidelines for Louisiana growers, addressing emerging threats like target spot of cotton and Fusarium head blight of wheat.

• Immunology
• Infection Immunology
• Respiratory Viral Infections
• +۶ مورد دیگر

Prof. Dunja Bruder is a university professor of infection immunology at the Institute of Medical Microbiology and Hospital Hygiene at Otto von Guericke University (OVGU) and Head of the Immune Regulation Research Group at the Helmholtz Center for Infection Research (HZI). She obtained her PhD in immunology from TU Braunschweig and completed postdoctoral training at Harvard Medical School and Yale University School of Medicine. Her research focuses on immune regulation in respiratory viral infections, chronic inflammatory lung diseases, and mucosal immunity. She leads two research groups and holds leadership roles in the Research Focus on Respiratory Viral Infections (HZI), the CRC 854, and the Otto-von-Guericke Graduate Academy. Her work integrates innate and adaptive immunity, with particular emphasis on T-cell responses, microbiota interactions, and vaccine development. She also contributes to teaching in master's programs and human medicine. Education Bachelor/Master: Biotechnology, Technical University of Braunschweig PhD (1996–1999): Immunodominance and T-cell responses to bacterial toxins, HZI Habilitation (2009): Immunology, Hannover Medical School Research Interests Bruder’s work examines immune responses to respiratory pathogens like influenza and SARS-CoV-2, the role of epithelial-T-cell interactions in asthma, and the modulation of immune defenses by microbiota. She investigates vaccine strategies using defective interfering particles and antigen-targeting approaches. Her studies also address antitumor immune training via viral infections and metabolic control of T-cell function in asthma endotypes. Key Contributions She pioneered the analysis of alveolar macrophage dysfunction in chronic lung diseases and demonstrated the protective role of IL-33 in microbiota-mediated antibacterial defenses. Her team developed predictive models for influenza infection using hematological data and identified CD47 as a critical regulator of antiviral macrophage activity. Labs/Teams Leads the Immune Regulation Group at HZI and collaborates with the Institute of Medical Microbiology at OVGU. Active in the HZI’s Respiratory Viral Infections Research Focus and the CRC 854.

Jaap Keijerمشاهده پروفایل

استاد

• Energy metabolism
• Mitochondrial function
• Metabolic pathways
• +۷ مورد دیگر

Jaap Keijer is a Full Professor and Chairholder in the Department of Human and Animal Physiology at Wageningen University & Research. His research focuses on metabolic physiology, particularly energy metabolism, mitochondrial function, and the interplay between diet, aging, and chronic metabolic diseases. He leads projects investigating nicotinamide nucleotide transhydrogenase (NNT) in energy metabolism, galactose's effects on metabolic programming, and the role of environmental factors like hypoxia in muscle physiology. He serves on the editorial board of Molecular Nutrition and Food Research and advises the German Institute of Human Nutrition. His work integrates molecular, cellular, and whole-organism approaches to understand health and disease mechanisms. Key research themes include metabolic adaptations in obesity, mitochondrial dysfunction in aging, and translational biomarker development for physical activity and metabolic health. Dr. Keijer teaches courses on molecular nutritional physiology, model organisms for lifespan research, and dissection-free human/animal physiology. His projects address clinical challenges such as sarcopenia, atrial fibrillation, and nutrient interventions for metabolic disorders. Recent studies explore dietary galactose's programming effects on intestinal metabolism and the impact of NNT deficiency on cardiac health. His lab employs advanced techniques like single-cell transcriptomics and Seahorse extracellular flux analysis to study metabolic pathways in humans and animal models. Publications emphasize mitochondrial dysfunction, metabolic biomarkers, and translational models for aging and disease. His work bridges basic research and clinical applications, aiming to improve metabolic health through dietary and lifestyle interventions. Current initiatives include developing a human gut-on-a-chip model and validating integrative biomarkers for physical activity in adolescents.

• Internal Medicine
• Clinical Quality Improvement
• Cardiovascular Disease Management
• +۳ مورد دیگر

Margaret Izabella Chustecki is an Associate Clinical Professor at the Yale School of Medicine's Department of Internal Medicine. She obtained her MD from Warsaw Medical School (1988) and an MBA from the Yale School of Management (2009). Her clinical practice focuses on improving healthcare efficiency through quality programs achieving NCQA accreditation and implementing initiatives like Meaningful Use and PQRS. She coordinates medical education for trainees while maintaining an active clinical practice. Education: MD - Warsaw Medical School (1988), MBA - Yale School of Management (2009) Clinical Experience: Extensive inpatient/outpatient internal medicine, hospitalist service leadership Practice Management: Founded Internal Medicine of Greater New Haven in 2003 Her research interests center on cardiovascular disease management, diabetes therapies, and healthcare quality improvement. She has led over 30 clinical trials evaluating treatments for cardiovascular conditions, diabetes, COPD, migraines, and osteoarthritis. Key areas of investigation include statin efficacy, anticoagulant therapies, and novel diabetes medications. Dr. Chustecki's clinical trials portfolio demonstrates expertise in cardiology, endocrinology, and gastroenterology. Recent studies focus on residual cardiovascular risk reduction, type 2 diabetes combination therapies, and migraine treatment innovations. Her work bridges clinical practice improvements with rigorous evidence-based research. Teaching contributions include supervising Yale medical students, PA trainees, and residents in both hospital and ambulatory settings. She actively participates in medical education program development and interprofessional team coordination. Labs/Teams: Collaborates with Yale New Haven Hospital teams in clinical trial execution and quality improvement initiatives.

• Malaria Research
• Infectious Disease Epidemiology
• Vector Biology
• +۳ مورد دیگر

Morgan Goheen is a Clinical Fellow and Instructor in the Section of Infectious Diseases at Yale School of Medicine. His research focuses on malaria transmission dynamics, particularly the impact of antimalarials on mosquito vectors and drug resistance in sub-Saharan Africa. He is affiliated with the EMD (Epidemiology of Microbial Diseases) program at Yale School of Public Health, collaborating with mentors Prof. Sunil Parikh and Dr. Amy Bei. His work combines field research in Burkina Faso with lab-based studies to explore vector biology, transmission-blocking interventions, and the effects of long-acting antimalarials on parasite development. Educated at Princeton University (AB, Molecular Biology), University of North Carolina at Chapel Hill (MD/PhD, Microbiology and Immunology), he has clinical training through Yale’s Internal Medicine residency and Physician-Scientist Training Program. His research has addressed host iron metabolism’s role in malaria susceptibility, with findings published in high-impact journals. Key research interests include: mosquito salivary antigens as transmission biomarkers, vector-parasite-drug interactions, and global health strategies to combat antimicrobial resistance. His recent Centennial Travel Award supports fieldwork in Burkina Faso, studying antimalarial exposure in mosquitoes and its implications for resistance spread. Mentored by EMD faculty in translational malaria research Recipient of Centennial Travel Award for tropical disease research Published over 20 peer-reviewed articles on malaria pathogenesis and clinical interventions His clinical and research activities reflect a commitment to addressing global health disparities through interdisciplinary approaches, bridging basic science, field epidemiology, and clinical practice.